Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy.
Saved in:
| Title: | Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy. |
|---|---|
| Authors: | Wykoff CC; Retina Consultants of Houston, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas. Electronic address: charleswyckoff@gmail.com., Rosenfeld PJ; University of Miami Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida., Waheed NK; Tufts Medical Center, Boston, Massachusetts., Singh RP; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio., Ronca N; Apellis Pharmaceuticals, Leominster, Massachusetts., Slakter JS; New York University School of Medicine, New York, New York., Staurenghi G; University of Milan-Bicocca: Universita degli Studi di Milano-Bicocca, Milan, Italy., Monés J; Barcelona Macula Foundation, Barcelona, Spain., Baumal CR; Tufts Medical Center, Boston, Massachusetts., Saroj N; Principal, All Eyes Consulting, LLC, New York, New York., Metlapally R; Apellis Pharmaceuticals, Leominster, Massachusetts., Ribeiro R; Apellis Pharmaceuticals, Leominster, Massachusetts. |
| Source: | Ophthalmology [Ophthalmology] 2021 Sep; Vol. 128 (9), pp. 1325-1336. Date of Electronic Publication: 2021 Mar 10. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
